Abhishek Chatterjee retweeted
Chemistry Professor Abhishek Chatterjee received a 2026 Ono Pharma Foundation (@OnoInitiative) Breakthrough Science Initiative Award, which includes $1 million in funding for his innovative gene therapy research. on.bc.edu/BreakthroughSciIni…
Abhishek Chatterjee retweeted
Welcome Senior Editor Abhishek Chatterjee, PhD, who brings expertise in chemical and synthetic biology, proteomics, novel bioconjugation chemistries, and therapeutic protein conjugates. Learn more about Molecular Cancer Therapeutics: brnw.ch/21x3LB2 @BostonCollege
Abhishek Chatterjee retweeted
Co-Translational Incorporation of (R)- and (S)-β2-Hydroxyacids In Vivo: Directed Evolution of Efficient Aminoacyl-tRNA Synthetases | Journal of the American Chemical Society pubs.acs.org/doi/10.1021/jac…
Abhishek Chatterjee retweeted
A facile chemical strategy to synthesize precise AAV-protein conjugates for targeted gene delivery dlvr.it/TMfgwR
Abhishek Chatterjee retweeted
Happy to see this new T7 replicon based orthogonal replication system in E. coli. Congrats to the Diercks and Schultz lab teams at Scripps Research! science.org/doi/10.1126/scie…
Abhishek Chatterjee retweeted
I discuss the urgent crisis from the loss of federal support of science in the US and recent clinical gene editing breakthroughs with @WalterIsaacson & @amanpour on @AmanpourCoPBS, airing on @PBS tonight at 11 pm ET, and on @cnni earlier today. Pls share!
youtube.com/watch?v=8YhJM6zx…
Abhishek Chatterjee retweeted
Today in @ScienceMagazine we report the development of a laboratory-evolved CRISPR-associated transposase (evoCAST) that supports therapeutically relevant levels of RNA-programmable gene insertion in human cells, a collaboration with @SternbergLab.
1/13
drive.google.com/file/d/1I-U…
Abhishek Chatterjee retweeted
Writing in @J_A_C_S, we report a sugar-derived single-addition monomer that can be added together with other monomers in #ROMP and install functional groups at the chain end of metathesis polymers. #glycotime #polymer #NSFfunded
pubs.acs.org/doi/10.1021/jac…
Abhishek Chatterjee retweeted
NIH is centralizing peer review of all applications for grants, cooperative agreements and research and development contracts within the agency’s @CSRpeerreview. This is expected to save NIH more than $65 million annually & make the review process more efficient. go.nih.gov/iGmUyfH
Abhishek Chatterjee retweeted
This isn't science fiction. This is real sequencing biotechnology just introduced by Roche. Wild and wonderful.
Abhishek Chatterjee retweeted
We are excited to report the discovery of TIGRs, a widely-occurring RNA-guided system found in bacteria and their viruses. TIGRs consist of a peculiar repeat region which is transcribed into RNA and processed into multiple guide RNAs to direct TIGR-associated proteins to their DNA targets. science.org/doi/10.1126/scie…
Abhishek Chatterjee retweeted
Basic science is inspired by curiosity, accountable to evidence, and subject to peer review. Politics should have no role.
Abhishek Chatterjee retweeted
1/ After residency at Mass General Hospital, I reported to Atlanta to meet my fellow CDC Epidemic Intelligence Service Officers.
I have never felt so intimidated by my peers
The best and the brightest, they were star clinicians, had served in disaster zones; MD/PhDs and MSF.
Abhishek Chatterjee retweeted
It’s been a tough few weeks. My 10yo daughter was diagnosed with a very rare, aggressive cancer called interdigitating dendritic cell sarcoma (IDCS). I’m reaching out to identify clinicians/patients who have encountered pediatric IDCS, indeterminate dendritic cell histiocytosis or other (non-LCH) histiocytic sarcomas cases.
I'm trying to understand non-surgical chemo and targeted therapy options, new pathology markers to better diagnose subtypes/treatments, and any data on progression in pediatric patients. Please feel free to share – I’m trying to cast a wide net due to the rarity of this condition and how little is known.
People can contact me directly at my first name (as written in my profile) at octant.bio.
Abhishek Chatterjee retweeted
Last year, $9B of the $35B that the National Institutes of Health (NIH) granted for research was used for administrative overhead, what is known as “indirect costs.” Today, NIH lowered the maximum indirect cost rate research institutions can charge the government to 15%, above what many major foundations allow and much lower than the 60%+ that some institutions charge the government today. This change will save more than $4B a year effective immediately.
Abhishek Chatterjee retweeted
This rate of validation suggests that antibodies should be considered non-specific until proven otherwise:
357 validated out of 1,124 tested.
.
Abhishek Chatterjee retweeted
Thoroughly enjoyed sharing my research on engineering aminoacyl-tRNA synthetases without relying on ribosomal translation, published earlier this year.
Thank you Prof. Ruchi Anand (@ruchianand1975 ) and @Chemistry_IITB for hosting me!
Seminar by Chintan Soni (Department of Chemistry, Boston College, USA) on "Engineering aminoacyl-tRNA synthetases for the synthesis of sequence defined biopolymers" at 11:00 hours today in seminar room (#350) @cpsoni_74



























